Is Pharmaceutical Giant Bristol-Myers Squibb (BMY) an Opportunity?

When people see a greater than 20% stock price plunge, they panic. Whereas value growth investors like me, salivate. A 20% plunge in one of the world’s biggest pharmaceuticals Bristol-Myers Squibb (BMY) in the past week is definitely an opportunity. Sometimes its hard to go against the crowd, and also accept being criticized at times…

Continue Reading →